Presentation ESC 2024 QUADRO Phase III Study: Efficacy and Safety of the new Quadruple SPC Perindopril/Indapamide/Amlodipine/Bisoprolol in Patients with Resistant Hypertension Presenter: Stefano Taddei August 31, 2024